Veterans Affairs News and Research

RSS

Drug pravastatin may provide a previously unknown cardiovascular benefit

The drug pravastatin, which is used widely to decrease high cholesterol, may provide a previously unknown cardiovascular benefit in addition to lowering lipids.

20 Nov 2005

Lowering calorie intake may help Parkinson's disease

A new Oregon Health & Science University and Portland Veterans Affairs Medical Center study suggests that early-stage Parkinson's disease patients who lower their calorie intake may boost levels of an essential brain chemical lost from the neurodegenerative disorder.

20 Nov 2005

The Medicare Drug Benefit: A Prescription for Confusion

If many seniors are scratching their heads about the new Medicare prescription drug plan, so are the experts.

20 Nov 2005

Obstructive sleep apnea significantly increases the risk of stroke

An observational study of more than 1,000 patients at the Yale Center for Sleep Medicine found that obstructive sleep apnea significantly increases the risk of stroke or death from any cause, and that the risk is linked to sleep apnea severity.

13 Nov 2005

Cholesterol lowering drugs do not appear to decrease the risk of melanoma

No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.

7 Nov 2005

America will not have a high-quality health system if equal attention is not given to mental health issues and substance-use problems

Without a comprehensive strategy to improve the quality of health care for people with mental conditions and alcohol or drug problems, high-quality care in the nation's overall health system and better health for the public are goals that will remain unmet

7 Nov 2005

Type 2 diabetes and depression can be a fatal mix

Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.

27 Oct 2005

Antisense molecules may hold promise in treating brain chemical problems such as Alzheimer's

Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer's disease, says the principal investigator of research published in an early on-line version of Peptides.

25 Oct 2005

Defibrillators plentiful in schools but not senior centers

A greater percentage of high schools had automated external defibrillators (AEDs) - devices that can be used to treat cardiac arrest victims - than senior centers, despite the fact that cardiac arrests appear more common in senior centers, according to a study by University of Iowa researchers.

20 Oct 2005

Discovery could lead to tests for the clinic or battlefield to diagnose ailments with just a few drops of blood

A way to detect fragments of broken brain cells that leak into the bloodstream may help doctors more quickly and precisely treat people with severe head injuries or brain diseases, say researchers at the University of Florida's McKnight Brain Institute.

17 Oct 2005

Combining alcoholics anonymous and treatment works best

Most clinical studies examine individuals either during or immediately following treatment. A study in the October issue of Alcoholism: Clinical & Experimental Research tracks individuals for 16 years who have first acknowledged their alcohol-use problems and then chosen Alcoholics Anonymous (AA), treatment, or both.

13 Oct 2005

Novel therapies for pleural mesothelioma

Researchers at New York University School of Medicine and Wayne State University have found a molecule that reveals the early stages of pleural mesothelioma, a chest cancer caused by asbestos. The finding opens the way to a blood test for the disease, according to a new study published in the Oct. 13 issue of The New England Journal of Medicine.

12 Oct 2005

Screening for cardiovascular risk by measuring blood levels of C-reactive protein should not be advocated

C-reactive protein (CRP) is released by the liver in response to inflammation related to an infection, injury, or conditions such as arthritis. Inflammation also has been associated with the cause and progression of cardiovascular disease, particularly in the build up of fatty deposits in the lining of arteries.

10 Oct 2005

Cost-effectiveness of potentially life-saving implantable cardioverter defibrillators (ICD) is an important public health issue

The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.

5 Oct 2005

Ischemic brain injury - another promising avenue for stem cell therapy

Adult stem cell therapy quickly and significantly improves recovery of motor function in an animal model for the ischemic brain injury that occurs in about 10 percent of babies with cerebral palsy, researchers report.

4 Oct 2005

Protein found in the brain is genetically linked to alcoholism and anxiety

The researchers studied rats selectively bred for high alcohol preference (P rats), which were found to have high anxiety levels and consume greater amounts of alcohol than alcohol non-preferring (NP) rats.

3 Oct 2005

No specific antiretroviral drug-related "Crix belly" syndrome

Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).

28 Sep 2005

$Statin use associated with a 36 percent reduction in risk of fracture$